Pfizer's Innovative Drug Pipeline Provides Ample Reason To Buy It Here

J Studios Investment Thesis I think it is safe to say that Pfizer Inc. (NYSE:PFE) is probably one of the least wanted stocks, not only in the pharmaceutical complex of stocks but in the broader view of the market. Pfizer has been plagued by a myriad of issues that are posing severe headwinds for the company since the world emerged from the pandemic, causing acute decelerations in the company's COVID-19 vaccine business. In addition, Pfizer has to deal with high costs across the board while building an innov ...